Italia markets closed

AFMD May 2024 10.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,30000,0000 (0,00%)
In data: 09:47AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,3000
Aperto0,3000
Denaro0,0000
Lettera0,0500
Prezzo d'esercizio10,00
Scadenza2024-05-17
Min-Max giorno0,3000 - 0,3000
Contratto - Min-MaxN/D
Volume1
Open Interest3
  • GlobeNewswire

    Affimed Announces Listing Transfer to Nasdaq Capital Markets

    MANNHEIM, Germany, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received approval from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) to transfer the listing of its shares from the Nasdaq Global Market to the Nasdaq Capital Market. This transfer is effective as of the opening of bu

  • GlobeNewswire

    Affimed Announces Acceptance of an Abstract Comparing NK Cells Redirected by Innate Cell Engagers and CAR-NK Cells for Poster Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer

    MANNHEIM, Germany, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that an abstract with a comparison of NK cell redirected by the Company’s innate cell engagers (ICE®) versus CAR-NK cells has been accepted for poster presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), which will be he

  • GlobeNewswire

    Affimed to Present at the Cantor Global Healthcare Conference 2023

    MANNHEIM, Germany, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Financial Officer, Angus Smith, will participate in a fireside chat at the Cantor Global Healthcare Conference 2023 on Thursday, September 28, 2023 at 1:15 p.m. Eastern Daylight Time / 19:15 Central European Time. A live webcast of the present